Citation: Da. Hart et Sp. Lenz, MULTIPLE DAILY INJECTIONS OF NZB W MICE WITH LICL LEADS TO THE LONG-TERM SURVIVAL OF A HIGH PERCENTAGE (80-PERCENT) OF THE ANIMALS/, Journal of trace and microprobe techniques, 15(2), 1997, pp. 219-227
Citation: Da. Hart et Sp. Lenz, INFLUENCE OF GENDER AND TIMING OF INITIATION OF TREATMENT ON LICL ENHANCEMENT OF NZB W SURVIVAL/, Journal of trace and microprobe techniques, 15(1), 1997, pp. 101-107
Citation: Sp. Lenz et al., EVIDENCE THAT LITHIUM-CHLORIDE TREATMENT OF FEMALE NZB W MICE DOES NOT INFLUENCE AUTOANTIBODY PROFILES IN THIS MURINE MODEL OF SYSTEMIC LUPUS-ERYTHEMATOSUS/, Journal of trace and microprobe techniques, 15(1), 1997, pp. 109-116
Citation: Sp. Lenz et Da. Hart, LICL TREATMENT OF FEMALE NZB W MICE LEADS TO ALTERATIONS IN GENE-EXPRESSION IN RENAL TISSUE/, Journal of trace and microprobe techniques, 15(1), 1997, pp. 117-125
Citation: Sp. Lenz et al., LITHIUM-CHLORIDE ENHANCES SURVIVAL OF NZB W LUPUS MICE - INFLUENCE OFMELATONIN AND TIMING OF TREATMENT/, International journal of immunopharmacology, 17(7), 1995, pp. 581-592
Citation: Da. Hart et al., PARTIAL CHARACTERIZATION OF THE ENHANCED SURVIVAL OF FEMALE NZB W MICE TREATED WITH LITHIUM-CHLORIDE/, International journal of immunopharmacology, 16(10), 1994, pp. 825-833
Authors:
MURPHY PG
LENZ SP
DOBSON M
ARNDT AD
HART DA
Citation: Pg. Murphy et al., PURIFICATION AND CHARACTERIZATION OF THE PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1, PAI-2, AND PN-1 FROM THE HUMAN GLIOBLASTOMA U138, Biochemistry and cell biology, 71(5-6), 1993, pp. 248-254